Subsidiary to develop and potentially commercialize late-stage migraine and neurological disorder product development portfolio in China and other ... read more
Biohaven Announces Formation Of BioShin, A Wholly Owned Asia-Pacific Subsidiary
Biohaven Announces Formation Of BioShin, A Wholly Owned Asia-Pacific Subsidiary